HIV-fertőzés: vizsgálatok itt: Mexikó

In Mexikó 13 Also abroad 789

13 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
Where
Guadajalara, Mérida, Mexico City, San Pedro Garza García
Életkor
12 év and over
People
564 worldwide
Run by
ViiV Healthcare
See details and how to joinNCT07650916 · EU 2024-518511-19-00
No phaseCsak meghívásos
Effect of Omega-3 Supplementation on Pregnant Outcomes and Inflammation Markers of Women Infected With HIV Using Antiretroviral Therapy
Where
Mexico City
Életkor
18 év and over
People
92
Run by
Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes
See details and how to joinNCT06971445
2/3. fázisTaking people
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Where
León, Veracruz
Életkor
18 év and over
People
570 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07266831 · EU 2025-522519-40-00
No phaseTaking people
Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
Where
Mexico City
Életkor
18 év to 99 év
People
140 worldwide
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT04052022
2. fázisTaking people
Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
Where
Coyoacán, Mérida, Mexico City
Életkor
4 hét to 11 év
People
84 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT04375800
4. fázisTaking people
Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Compared With Darunavir/Cobicistat Plus Tenofovir Alafenamide/Emtricitabine in Virologically Suppressed People Living With HIV at 24 and 48 Weeks of Follow-up
Where
Mexico City
Életkor
18 év and over
People
78
Run by
Instituto Mexicano del Seguro Social
See details and how to joinNCT07678268
No phaseNot yet taking people in Mexikó
Coronary Artery Calcium Score in HIV Mexican Population (The CACsHIVMex Study)
Where
León
Életkor
18 év and over
People
384
Run by
Instituto Mexicano del Seguro Social
See details and how to joinNCT07662161
No phaseCsak meghívásos
Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDS
Where
México
Életkor
18 év to 80 év
People
196
Run by
Centro de Investigación en. Enfermedades Infecciosas, Mexico
See details and how to joinNCT03856229
3. fázisTaking people
DOR/TDF/3TC COmpared With BIC/FTC/TAF in ART-Naïve People Living With HIV and Overweight or Obesity
Where
Mexico City
Életkor
18 év to 70 év
People
306
Run by
José Antonio Mata Marín
See details and how to joinNCT07075146
4. fázisTaking people
Efficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug REgimen With BIC/FTC/TAF or DTG/3TC/ABC in ViroLogically SupprEssed PeopLe Living With HIV After 24 and 48 Weeks of Follow-Up
Where
Mexico City
Életkor
18 év to 70 év
People
156
Run by
José Antonio Mata Marín
See details and how to joinNCT07138144
4. fázisTaking people
Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience
Where
Mexico City
Életkor
18 év and over
People
124
Run by
Instituto Mexicano del Seguro Social
See details and how to joinNCT07031063
4. fázisTaking people
Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabine in Virologically Suppressed HIV-1-positive Individuals in Mexico
Where
Mexico City
Életkor
18 év to 70 év
People
138
Run by
José Antonio Mata Marín
See details and how to joinNCT06907056
No phaseTaking people
Caspofungin for Pneumocystis Pneumonia in PLWHIV.
Where
Mexico City
Életkor
18 év to 60 év
People
60
Run by
Instituto Nacional de Enfermedades Respiratorias
See details and how to joinNCT06691321